DuPont falls on earnings, but investors might want to buy on weakness

The market didn't like DuPont's (DD) third-quarter earnings report, sending shares of the chemical giant down as much as three percent during Tuesday's session. This component of the Dow Jones Industrial Average ($INDU) easily beat Wall Street's profit estimate, but sales across all DuPont's businesses were down.

DuPont's stock has been a market beater so far this year, rising 37 percent to outpace the S&P 500 ($INX) by 15 percentage points. Perhaps today's stumble offers investors a chance to buy the blue chip on weakness. Shares go for just 16 times forward earnings, offering a discount of about 20 percent to the broader market. That's an intriguing relative valuation. Perhaps most attractive is DuPont's dividend. The share-price slide has boosted the yield to 4.8 percent.
Read Full Story

Markets

DJIA 21,835.93 -63.96 -0.29%
NASDAQ 6,275.72 -21.76 -0.35%
S&P 500 2,445.12 -7.39 -0.30%
NIKKEI 225 19,434.64 50.80 0.26%
HANG SENG 27,401.67 246.99 0.91%
DAX 12,190.06 -39.28 -0.32%
USD (per EUR) 1.18 0.01 0.43%
USD (per CHF) 0.97 0.00 -0.36%
JPY (per USD) 109.11 -0.61 -0.56%
GBP (per USD) 1.28 0.00 -0.23%

Can't get enough business news?

Sign up for Finance Report by AOL and get everything from retailer news to the latest IPOs delivered directly to your inbox daily!

Subscribe to our other newsletters

Emails may offer personalized content or ads. Learn more. You may unsubscribe any time.